Cited by 626Alzheimer's disease research and treatmentsSphingolipid Metabolism and SignalingDementia and Cognitive Impairment Research

The DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.

Substantial sulfatide deficiency and ceramide elevation in very early Alzheimer's disease: potential role in disease pathogenesis

Han, Xianlin, M. Holtzman, David, W. McKeel, Daniel, Kelley, John, Morris, John C.·2002·Journal of Neurochemistry

DOI 10.1046/j.1471-4159.2002.00997.x

Open this paper in CoChat — free account

Abstract

In addition to pathology in the gray matter, there are also abnormalities in the white matter in Alzheimer's disease (AD). Sulfatide species are a class of myelin‐specific sphingolipids and are involved in certain diseases of the central nervous system. To assess whether sulfatide content in gray and white matter in human subjects is associated with both the presence of Alzheimer's disease (AD) pathology as well as the stage of dementia, we analyzed the sulfatide content of brain tissue lipid extracts by electrospray ionization mass spectrometry from 22 subjects whose cognitive status at time of death varied from no dementia to very severe dementia. All subjects with dementia had AD pathology. The results demonstrate that: (i) sulfatides were depleted up to 93% in gray matter and up to 58% in white matter from all examined brain regions from AD subjects with very mild dementia, whereas all other major classes of lipid (except plasmalogen) in these subjects were not altered in comparison to those from age‐matched subjects with no dementia; (ii) there was no apparent deficiency in the biosynthesis of sulfatides in very mild AD subjects as characterized by the examination of galactocerebroside sulfotransferase activities in post‐mortem brain tissues; (iii) the content of ceramides (a class of potential degradation products of sulfatides) was elevated more than three‐fold in white matter and peaked at the stage of very mild dementia. The findings demonstrate that a marked decrease in sulfatides is associated with AD pathology even in subjects with very mild dementia and that these changes may be linked with early events in the pathological process of AD.

Integrity signals

Registry

Crossref · 10.1046/j.1471-4159.2002.00997.x

Cites

56 of 56 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

A RAPID METHOD OF TOTAL LIPID EXTRACTION AND PURIFICATION
Bligh, E. G., & Dyer, W. J. (1959) · Canadian Journal of Biochemistry and Physiology · doi:10.1139/o59-099 · Cited by 54,751
The Clinical Dementia Rating (CDR): Current version and scoring rules
Morris, J. C. (1993) · Neurology · doi:10.1212/wnl.43.11.2412-a · Cited by 9,882
Self-citation
Functions of Ceramide in Coordinating Cellular Responses to Stress
Hannun, Y. A. (1996) · Science · doi:10.1126/science.274.5294.1855 · Cited by 1,612
A white matter disorder in dementia of the Alzheimer type: A pathoanatomical study
Brun, A., & Englund, E. (1986) · Annals of Neurology · doi:10.1002/ana.410190306 · Cited by 1,014
Alzheimer's Disease--Genotypes, Phenotype, and Treatments
Selkoe, D. J. (1997) · Science · doi:10.1126/science.275.5300.630 · Cited by 879
REGULATION OF CERAMIDE PRODUCTION AND APOPTOSIS
Kolesnick, R., & Krönke, M. (1998) · Annual Review of Physiology · doi:10.1146/annurev.physiol.60.1.643 · Cited by 803
Ceramide in the eukaryotic stress response
Hannun, Y. A., & Luberto, C. (2000) · Trends in Cell Biology · doi:10.1016/s0962-8924(99)01694-3 · Cited by 727
Clinicopathologic Studies in Cognitively Healthy Aging and Alzheimer Disease: Relation of Histologic Markers to Dementia Severity, Age, Sex, and Apolipoprotein E Genotype
Berg, L., McKeel, D. W., Miller, J. P., Storandt, M., Rubin, E. H., Morris, J. C., Baty, J., Coats, M., Norton, J., Goate, A. M., et al. (1998) · Archives of Neurology · doi:10.1001/archneur.55.3.326 · Cited by 657
Self-citation
Sphingolipids—The Enigmatic Lipid Class: Biochemistry, Physiology, and Pathophysiology
Merrill, A. H., Schmelz, E.-M., Dillehay, D. L., Spiegel, S., Shayman, J. A., Schroeder, J. J., Riley, R. T., Voss, K. A., & Wang, E. (1997) · Toxicology and Applied Pharmacology · doi:10.1006/taap.1996.8029 · Cited by 643
Myelination in the Absence of Galactocerebroside and Sulfatide: Normal Structure with Abnormal Function and Regional Instability
Coetzee, T., Fujita, N., Dupree, J. L., Shi, R., Blight, A. R., Suzuki, K., Suzuki, K., & Popko, B. (1996) · Cell · doi:10.1016/s0092-8674(00)80093-8 · Cited by 624

Show all 56 references

Research works printed but not linked: 5

10.1139/y59-099 · DOI · Paper page
10.1042/bj3520079 · DOI
Kolodny E. H., 1995, The Metabolic and Molecular Bases of Inherited Diseases, 2693
Mattson M. P., 1997, Mother's legacy: mitochondrial DNA mutations and Alzheimer's disease, Trends Neurosci., 20, 373
Suzuki K., 1995, The Metabolic and Molecular Bases of Inherited Diseases, 2671

Sorted by citations

Items 101–200 of 625

White matter damage of patients with Alzheimer’s disease correlated with the decreased cognitive function
Duan, J., Wang, H., Xu, J., Lin, X. Z., Chen, S., Kang, Z., & Yao, Z. (2006) · Surgical and Radiologic Anatomy · doi:10.1007/s00276-006-0111-2 · Cited by 115
When astrocytes become harmful: Functional and inflammatory responses that contribute to Alzheimer's disease
Avila-Muñoz, E., & Arias, C. (2014) · Ageing Research Reviews · doi:10.1016/j.arr.2014.07.004 · Cited by 114
Defective macroautophagic turnover of brain lipids in the TgCRND8 Alzheimer mouse model: prevention by correcting lysosomal proteolytic deficits
Yang, D.-S., Stavrides, P., Saito, M., Kumar, A., Rodriguez-Navarro, J. A., Pawlik, M., Huo, C., Walkley, S. U., Saito, M., Cuervo, A. M., et al. (2014) · Brain · doi:10.1093/brain/awu278 · Cited by 114
Alterations in lipid homeostasis of mouse dorsal root ganglia induced by apolipoprotein E deficiency: a shotgun lipidomics study
Cheng, H., Jiang, X., & Han, X. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04342.x · Cited by 111
Self-citation
Myelin lipid metabolism and its role in myelination and myelin maintenance
Barnes-Vélez, J. A., Aksoy Yasar, F. B., & Hu, J. (2023) · The Innovation · doi:10.1016/j.xinn.2022.100360 · Cited by 73
Alterations in multiple measures of white matter integrity in normal women at high risk for Alzheimer's disease
Gold, B. T., Powell, D. K., Andersen, A. H., & Smith, C. D. (2010) · NeuroImage · doi:10.1016/j.neuroimage.2010.05.036 · Cited by 112
FTY720 (Fingolimod) Attenuates Beta-amyloid Peptide (Aβ42)-Induced Impairment of Spatial Learning and Memory in Rats
Asle‐Rousta, M., Kolahdooz, Z., Oryan, S., Ahmadiani, A., & Dargahi, L. (2013) · Journal of Molecular Neuroscience · doi:10.1007/s12031-013-9979-6 · Cited by 112
Omega-3 fatty acids, lipids, and apoE lipidation in Alzheimer's disease: a rationale for multi-nutrient dementia prevention
Grimm, M. O. W., Michaelson, D. M., & Hartmann, T. (2017) · Journal of Lipid Research · doi:10.1194/jlr.r076331 · Cited by 114
Two endoplasmic reticulum (ER)/ER Golgi intermediate compartment-based lysine acetyltransferases post-translationally regulate BACE1 levels
Ko, M. H., & Puglielli, L. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m804901200 · Cited by 111
Cerebrospinal fluid sulfatide is decreased in subjects with incipient dementia
Han, X., Fagan, A. M., Cheng, H., Morris, J. C., Xiong, C., & Holtzman, D. M. (2003) · Annals of Neurology · doi:10.1002/ana.10618 · Cited by 113
Self-citation
Apolipoprotein E Affects Both Myelin Breakdown and Cognition: Implications for Age-Related Trajectories of Decline Into Dementia
Bartzokis, G., Lu, P. H., Geschwind, D. H., Tingus, K., Huang, D., Mendez, M. F., Edwards, N., & Mintz, J. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.03.024 · Cited by 109
AT-1 is the ER membrane acetyl-CoA transporter and is essential for cell viability
Jonas, M. C., Pehar, M., & Puglielli, L. (2010) · Journal of Cell Science · doi:10.1242/jcs.068841 · Cited by 108
Neurolipidomics: challenges and developments
Han, X. (2006) · Frontiers in bioscience · doi:10.2741/2258 · Cited by 110
Self-citation
The Impact of Vitamin E and Other Fat-Soluble Vitamins on Alzheimer´s Disease
Grimm, M. O. W., Mett, J., & Hartmann, T. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17111785 · Cited by 112
Consumption of a high‐fat diet, but not regular endurance exercise training, regulates hypothalamic lipid accumulation in mice
Borg, M. L., Omran, S. F., Weir, J. M., Meikle, P. J., & Watt, M. J. (2012) · The Journal of Physiology · doi:10.1113/jphysiol.2012.233288 · Cited by 108
In-Vial Dual Extraction for Direct LC-MS Analysis of Plasma for Comprehensive and Highly Reproducible Metabolic Fingerprinting.
Whiley, L., Godzień, J., Rupérez, F. J., Legido‐Quigley, C., & Barbas, C. (2012) · Analytical Chemistry · doi:10.1021/ac300716u · Cited by 107
Promotion of Oxidative Lipid Membrane Damage by Amyloid β Proteins
Murray, I. V. J., Sindoni, M. E., & Axelsen, P. H. (2005) · Biochemistry · doi:10.1021/bi050926p · Cited by 107
IPAF inflammasome is involved in interleukin-1β production from astrocytes, induced by palmitate; implications for Alzheimer's Disease
Liu, L., & Chan, C. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.08.016 · Cited by 108
Regulation of ceramide-induced neuronal death: Cell metabolism meets neurodegeneration
Arboleda, G., Morales, L. C., Benítez, B. A., & Arboleda, H. (2008) · Brain Research Reviews · doi:10.1016/j.brainresrev.2008.10.001 · Cited by 105
APP Function and Lipids: A Bidirectional Link
Grimm, M. O. W., Mett, J., Grimm, H. S., & Hartmann, T. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00063 · Cited by 104
Delineating Amyloid Plaque Associated Neuronal Sphingolipids in Transgenic Alzheimer’s Disease Mice (tgArcSwe) Using MALDI Imaging Mass Spectrometry
Kaya, I., Brinet, D., Michno, W., Syvänen, S., Sehlin, D., Zetterberg, H., Blennow, K., & Hanrieder, J. (2016) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.6b00391 · Cited by 101
Specific changes of sulfatide levels in individuals with pre‐clinical Alzheimer's disease: an early event in disease pathogenesis
Cheng, H., Wang, M., Li, J., Cairns, N. J., & Han, X. (2013) · Journal of Neurochemistry · doi:10.1111/jnc.12368 · Cited by 103
Self-citation
Myelin Basic Protein Associates with AβPP, Aβ 1-42 , and Amyloid Plaques in Cortex of Alzheimer's Disease Brain
Zhan, X., Jickling, G. C., Ander, B. P., Stamova, B. S., Liu, D., Kao, P. F., Zelin, M. A., Jin, L., DeCarli, C. S., & Sharp, F. R. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-142013 · Cited by 109
Lipid metabolism in Alzheimer’s disease
Liu, Q., & Zhang, J. (2014) · Neuroscience Bulletin · doi:10.1007/s12264-013-1410-3 · Cited by 101
Potential mechanisms contributing to sulfatide depletion at the earliest clinically recognizable stage of Alzheimer’s disease: a tale of shotgun lipidomics
Han, X. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04708.x · Cited by 101
Self-citation
Slow Excitotoxicity in Alzheimer's Disease
Ong, W.-Y., Tanaka, K., Dawe, G. S., Ittner, L. M., & Farooqui, A. A. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-121990 · Cited by 106
Cholinergic and glutamatergic alterations beginning at the early stages of Alzheimer disease: participation of the phospholipase A2 enzyme
Schaeffer, E. L., & Gattaz, W. F. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1092-0 · Cited by 98
Elevated cerebrospinal fluid sphingomyelin levels in prodromal Alzheimer's disease
Košiček, M., Zetterberg, H., Andreasen, N., Peter‐Katalinić, J., & Hecimovic, S. K. (2012) · Neuroscience Letters · doi:10.1016/j.neulet.2012.04.019 · Cited by 102
Lipid glycosylation: a primer for histochemists and cell biologists
Kopitz, J. (2016) · Histochemistry and Cell Biology · doi:10.1007/s00418-016-1518-4 · Cited by 97
Mass Spectrometry Imaging, an Emerging Technology in Neuropsychopharmacology
Shariatgorji, M., Svenningsson, P., & Andrén, P. E. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2013.215 · Cited by 99
Loss of ceramide synthase 2 activity, necessary for myelin biosynthesis, precedes tau pathology in the cortical pathogenesis of Alzheimer's disease
Couttas, T. A., Kain, N., Suchowerska, A. K., Quek, L., Turner, N. A., Fath, T., Garner, B., & Don, A. S. (2016) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2016.03.027 · Cited by 99
Low Plasma N-3 Fatty Acids and Dementia in Older Persons: The InCHIANTI Study
Cherubini, A., Andres-Lacueva, C., Martin, A., Lauretani, F., Iorio, A. D., Bartali, B., Corsi, A., Bandinelli, S., Mattson, M. P., & Ferrucci, L. (2007) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/62.10.1120 · Cited by 95
Mass Spectrometry Strategies for Clinical Metabolomics and Lipidomics in Psychiatry, Neurology, and Neuro-Oncology
Wood, P. L. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2013.167 · Cited by 95
Direct Infusion Mass Spectrometry for Metabolomic Phenotyping of Diseases
González‐Domínguez, R., Sayago, A., & Fernández‐Recamales, Á. (2016) · Bioanalysis · doi:10.4155/bio-2016-0202 · Cited by 100
Sphingolipids in neurodegeneration (with focus on ceramide and S1P)
Wang, G., & Bieberich, E. (2018) · Advances in Biological Regulation · doi:10.1016/j.jbior.2018.09.013 · Cited by 99
Disentangling Mitochondria in Alzheimer’s Disease
Johri, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222111520 · Cited by 103
Menaquinone-4 Concentration Is Correlated with Sphingolipid Concentrations in Rat Brain
Carrié, I., Vicaretti, R., Potvin, S., Ferland, G., Portoukalian, J., & Rochford, J. M. (2004) · Journal of Nutrition · doi:10.1093/jn/134.1.167 · Cited by 95
The brain lipidomes of subcortical ischemic vascular dementia and mixed dementia
Lam, S. M., Wang, Y., Duan, X., Wenk, M. R., Kalaria, R. N., Chen, C., Lai, M. K. P., & Shui, G. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.02.025 · Cited by 95
Lipid Metabolism Influence on Neurodegenerative Disease Progression: Is the Vehicle as Important as the Cargo?
Estes, R., Lin, B. C., Khera, A., & Davis, M. Y. (2021) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2021.788695 · Cited by 99
Inflammasome-mediated innate immunity in Alzheimer’s disease
Venegas, C., & Heneka, M. T. (2019) · The FASEB Journal · doi:10.1096/fj.201900439 · Cited by 93
Direct profiling of tissue lipids by MALDI-TOFMS
Jackson, S. N., & Woods, A. S. (2008) · Journal of Chromatography B · doi:10.1016/j.jchromb.2008.11.033 · Cited by 93
Quadratic trajectories of brain myelin content: unifying construct for neuropsychiatric disorders
Bartzokis, G. (2003) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2003.08.001 · Cited by 97
Autoantibodies in Alzheimer's disease: potential biomarkers, pathogenic roles, and therapeutic implications
Jianming, W., & Ling, L. (2016) · The Journal of Biomedical Research · doi:10.7555/jbr.30.20150131 · Cited by 87
An Improved High‐Throughput Lipid Extraction Method for the Analysis of Human Brain Lipids
Abbott, S. K., Jenner, A. M., Mitchell, T. W., Brown, S. H. J., Halliday, G. M., & Garner, B. (2013) · Lipids · doi:10.1007/s11745-013-3760-z · Cited by 88
Shedding Light on the Molecular Pathology of Amyloid Plaques in Transgenic Alzheimer’s Disease Mice Using Multimodal MALDI Imaging Mass Spectrometry
Kaya, I., Zetterberg, H., Blennow, K., & Hanrieder, J. (2018) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.8b00121 · Cited by 87
Sphingolipids in Alzheimer's disease, how can we target them?
Crivelli, S. M., Giovagnoni, C., Visseren, L., Scheithauer, A.-L., de Wit, N. M., den Hoedt, S., Losen, M. H., Mulder, M. T., Walter, J., de Vries, H. E., et al. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2019.12.003 · Cited by 88
Lipidomic profiling in mouse brain reveals differences between ages and genders, with smaller changes associated with α‐synuclein genotype
Rappley, I., Myers, D. S., Milne, S. B., Ivanova, P. T., LaVoie, M. J., Brown, H. A., & Selkoe, D. J. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06290.x · Cited by 87
Desorption Electrospray Ionization Mass Spectrometry Analysis of Lipids after Two-Dimensional High-Performance Thin-Layer Chromatography Partial Separation
Paglia, G., Ifa, D. R., Wu, C., Corso, G., & Cooks, R. G. (2010) · Analytical Chemistry · doi:10.1021/ac902325j · Cited by 86
Lipidomics in the study of lipid metabolism: Current perspectives in the omic sciences
Rolim, A. E. H., Henrique-Araújo, R., Ferraz, E. G., Dultra, F. K. A. A., & Fernandez, L. G. (2014) · Gene · doi:10.1016/j.gene.2014.10.039 · Cited by 89
FTY720/fingolimod, a sphingosine analogue, reduces amyloid-β production in neurons
Takasugi, N., Sasaki, T., Ebinuma, I., Osawa, S., Isshiki, H., Takeo, K., Tomita, T., & Iwatsubo, T. (2013) · PLoS ONE · doi:10.1371/journal.pone.0064050 · Cited by 85
The Cross-Talk Between Sphingolipids and Insulin-Like Growth Factor Signaling: Significance for Aging and Neurodegeneration
Jęśko, H. M., Stępień, A., Lukiw, W. J., & Strosznajder, R. P. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-1286-3 · Cited by 85
The utility of metabolomics in natural product and biomarker characterization
Cox, D. G., Oh, J., Keasling, A. W., Colson, K., & Hamann, M. T. (2014) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2014.08.007 · Cited by 84
Mitochondrial lipids in neurodegeneration
Aufschnaiter, A., Kohler, V., Diessl, J., Peselj, C., Carmona‐Gutiérrez, D., Keller, W., & Büttner, S. (2016) · Cell and Tissue Research · doi:10.1007/s00441-016-2463-1 · Cited by 91
Brain region‐specific amyloid plaque‐associated myelin lipid loss, APOE deposition and disruption of the myelin sheath in familial Alzheimer’s disease mice
Kaya, I., Jennische, E., Lange, S., Baykal, A. T., Malmberg, P., & Fletcher, J. S. (2020) · Journal of Neurochemistry · doi:10.1111/jnc.14999 · Cited by 85
Global changes of phospholipids identified by MALDI imaging mass spectrometry in a mouse model of Alzheimer's disease
Hong, J. H., Kang, J. W., Kim, D. K., Baik, S. H., Kim, K. H., Shanta, S. R., Jung, J. H., Mook-Jung, I., & Kim, K. P. (2016) · Journal of Lipid Research · doi:10.1194/jlr.m057869 · Cited by 83
Systems biology strategies to study lipidomes in health and disease
Hyötyläinen, T., & Orešič, M. (2014) · Progress in Lipid Research · doi:10.1016/j.plipres.2014.06.001 · Cited by 83
Lysophosphatidylcholine and Amide as Metabolites for Detecting Alzheimer Disease Using Ultrahigh-Performance Liquid Chromatography–Quadrupole Time-of-Flight Mass Spectrometry–Based Metabonomics
Cui, Y., Liu, X., Wang, M., Liu, L., Sun, X., Ma, L., Xie, W., Wang, C., Tang, S., Wang, D., et al. (2014) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0000000000000116 · Cited by 84
The Impact of Cholesterol, DHA, and Sphingolipids on Alzheimer’s Disease
Grimm, M. O. W., Zimmer, V. C., Lehmann, J., Grimm, H. S., & Hartmann, T. (2013) · BioMed Research International · doi:10.1155/2013/814390 · Cited by 85
Aberrant Upregulation of Astroglial Ceramide Potentiates Oligodendrocyte Injury
Kim, S.-J., Steelman, A. J., Zhang, Y., Kinney, H. C., & Li, J. (2011) · Brain Pathology · doi:10.1111/j.1750-3639.2011.00501.x · Cited by 82
Histology-Compatible MALDI Mass Spectrometry Based Imaging of Neuronal Lipids for Subsequent Immunofluorescent Staining
Kaya, I., Michno, W., Brinet, D., Iacone, Y., Zanni, G., Blennow, K., Zetterberg, H., & Hanrieder, J. (2017) · Analytical Chemistry · doi:10.1021/acs.analchem.7b00313 · Cited by 81
Dysfunctional Pro-Ceramide, ER Stress, and Insulin/IGF Signaling Networks with Progression of Alzheimer's Disease
de la Monte, S. M., Re, E. B., Longato, L., & Tong, M. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-111728 · Cited by 81
Amyloid‐β peptide enhances tumor necrosis factor‐α‐induced iNOS through neutral sphingomyelinase/ceramide pathway in oligodendrocytes
Zeng, C., Lee, J. T., Chen, H., Chen, S., Hsu, C. Y., & Xu, J. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03217.x · Cited by 80
Application of a novel metabolomic approach based on atmospheric pressure photoionization mass spectrometry using flow injection analysis for the study of Alzheimer׳s disease
González‐Domínguez, R., García‐Barrera, T., & Gómez‐Ariza, J. L. (2014) · Talanta · doi:10.1016/j.talanta.2014.07.075 · Cited by 79
Aging of the brain, neurotrophin signaling, and Alzheimer's disease: Is IGF1-R the common culprit?
Puglielli, L. (2008) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.01.010 · Cited by 61
Perspective: The Potential Role of Circulating Lysophosphatidylcholine in Neuroprotection against Alzheimer Disease
Semba, R. D. (2020) · Advances in Nutrition · doi:10.1093/advances/nmaa024 · Cited by 78
Myelin Injury and Degraded Myelin Vesicles in Alzheimer’s Disease
Zhan, X., Jickling, G. C., Ander, B. P., Liu, D., Stamova, B. S., Cox, C. D., Jin, L. W., DeCarli, C. S., & Sharp, F. R. (2014) · Current Alzheimer Research · doi:10.2174/1567205011666140131120922 · Cited by 80
Apolipoprotein E mediates sulfatide depletion in animal models of Alzheimer’s disease
Cheng, H., Zhou, Y., Holtzman, D. M., & Han, X. (2010) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2008.07.020 · Cited by 79
Self-citation
Selective desorption/ionization of sulfatides by MALDI-MS facilitated using 9-aminoacridine as matrix
Cheng, H., Sun, G., Yang, K., Gross, R. W., & Han, X. (2010) · Journal of Lipid Research · doi:10.1194/jlr.d004077 · Cited by 79
Self-citation
Opposing effects of apoE2 and apoE4 on microglial activation and lipid metabolism in response to demyelination
Wang, N., Wang, M., Jeevaratnam, S., Rosenberg, C., Ikezu, T. C., Shue, F., Doss, S. V., Alnobani, A., Martens, Y. A., Wren, M., et al. (2022) · Molecular Neurodegeneration · doi:10.1186/s13024-022-00577-1 · Cited by 82
Metabolomics in Alzheimer’s disease: The need of complementary analytical platforms for the identification of biomarkers to unravel the underlying pathology
González‐Domínguez, R., Sayago, A., & Fernández‐Recamales, Á. (2017) · Journal of Chromatography B · doi:10.1016/j.jchromb.2017.02.008 · Cited by 76
Strategies to Improve/Eliminate the Limitations in Shotgun Lipidomics
Hu, C., Duan, Q., & Han, X. (2019) · PROTEOMICS · doi:10.1002/pmic.201900070 · Cited by 80
Self-citation
Sets of coregulated serum lipids are associated with Alzheimer's disease pathophysiology
Barupal, D. K., Baillie, R., Fan, S., Saykin, A. J., Meikle, P. J., Arnold, M., Nho, K. T., Fiehn, O., Kaddurah‐Daouk, R., & Initiative, A. D. N. (2019) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1016/j.dadm.2019.07.002 · Cited by 68
Metabonomics: A Useful Tool for the Future Surgeon
Goldsmith, P., Fenton, H. M., Morris‐Stiff, G., Ahmad, N., Fisher, J., & Prasad, R. K. (2009) · Journal of Surgical Research · doi:10.1016/j.jss.2009.03.003 · Cited by 76
Sphingolipid Metabolism: A New Therapeutic Opportunity for Brain Degenerative Disorders
Pardo, A. D., & Maglione, V. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00249 · Cited by 75
Studies on Plasmalogen-Selective Phospholipase A2 in Brain
Farooqui, A. A. (2010) · Molecular Neurobiology · doi:10.1007/s12035-009-8091-y · Cited by 75
Palmitate-activated astrocytes via serine palmitoyltransferase increase BACE1 in primary neurons by sphingomyelinases
Liu, L., Martin, R., & Chan, C. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2012.05.017 · Cited by 75
Contribution of changes in ubiquitin and myelin basic protein to age-related cognitive decline
Wang, D.-S., Bennett, D. A., Mufson, E. J., Mattila, P. M., Cochran, E. J., & Dickson, D. W. (2003) · Neuroscience Research · doi:10.1016/j.neures.2003.10.002 · Cited by 72
Imaging mass spectrometry (IMS) of cortical lipids from preclinical to severe stages of Alzheimer's disease
Román, E. G. D. S., Manuel, I., Giralt, M. T., Ferrer, I., & Rodríguez‐Puertas, R. (2017) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2017.05.009 · Cited by 71
Age-Dependent Changes to Sphingolipid Balance in the Human Hippocampus are Gender-Specific and May Sensitize to Neurodegeneration
Couttas, T. A., Kain, N., Tran, C., Chatterton, Z., Kwok, J. B., & Don, A. S. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-171054 · Cited by 73
Sphingolipid Metabolism Correlates with Cerebrospinal Fluid Beta Amyloid Levels in Alzheimer’s Disease
Fonteh, A. N., Ormseth, C. H., Chiang, J., Cipolla, M., Arakaki, X., & Harrington, M. G. (2015) · PLoS ONE · doi:10.1371/journal.pone.0125597 · Cited by 72
Early limited nitrosamine exposures exacerbate high fat diet-mediated type 2 diabetes and neurodegeneration
Tong, M., Longato, L., & de la Monte, S. M. (2010) · BMC Endocrine Disorders · doi:10.1186/1472-6823-10-4 · Cited by 73
Lipids in Pathophysiology and Development of the Membrane Lipid Therapy: New Bioactive Lipids
Torres, M., Parets, S., Fernández-Díaz, J., Beteta-Göbel, R., Rodríguez-Lorca, R., Román, R., Lladó, V., Rosselló, C. A., Fernández‐García, P., & Escribá, P. V. (2021) · Membranes · doi:10.3390/membranes11120919 · Cited by 80
Novel molecular insights into the critical role of sulfatide in myelin maintenance/function
Palavicini, J. P., Wang, C., Chen, L., Ahmar, S., Higuera, J. D., Dupree, J. L., & Han, X. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13738 · Cited by 67
Self-citation
The role of apolipoprotein E in lipid metabolism in the central nervous system
Han, X. (2004) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-004-4009-z · Cited by 69
Self-citation
Myriocin Effect on Tvrm4 Retina, an Autosomal Dominant Pattern of Retinitis Pigmentosa
Piano, I., D’Antongiovanni, V., Novelli, E., Biagioni, M., Dei, M., Paroni, R. C., Ghidoni, R., Strettoi, E., & Gargini, C. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00372 · Cited by 68
X-ray Absorption Spectroscopy at the Sulfur K-Edge: A New Tool to Investigate the Biochemical Mechanisms of Neurodegeneration
Hackett, M. J., Smith, S., Paterson, P. G., Nichol, H. K., Pickering, I. J., & George, G. N. (2012) · ACS Chemical Neuroscience · doi:10.1021/cn200097s · Cited by 68
Pathological roles of ceramide and its metabolites in metabolic syndrome and Alzheimer's disease
Yuyama, K., Mitsutake, S., & Igarashi, Y. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2013.08.002 · Cited by 68
Ceramides and sphingomyelinases in senile plaques
Panchal, M., Gaudin, M., Lazar, A. N., Salvati, E., Rivals, I., Ayciriex, S., Dauphinot, L., Dargère, D., Auzeil, N., Masserini, M., et al. (2014) · Neurobiology of Disease · doi:10.1016/j.nbd.2014.01.010 · Cited by 69
The role of APP proteolytic processing in lipid metabolism
Grimm, M. O. W., Rothhaar, T. L., & Hartmann, T. (2011) · Experimental Brain Research · doi:10.1007/s00221-011-2975-6 · Cited by 70
The 5XFAD Mouse Model of Alzheimer’s Disease Exhibits an Age-Dependent Increase in Anti-Ceramide IgG and Exogenous Administration of Ceramide Further Increases Anti-Ceramide Titers and Amyloid Plaque Burden
Dinkins, M. B., Dasgupta, S., Wang, G., Zhu, G., He, Q., Kong, J. N., & Bieberich, E. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-150088 · Cited by 68
Fingolimod for multiple sclerosis and emerging indications: appropriate patient selection, safety precautions, and special considerations
Kleiter, I., Ayzenberg, I., & Hoepner, R. (2016) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s65558 · Cited by 70
Lipidome disruption in Alzheimer’s disease brain: detection, pathological mechanisms, and therapeutic implications
He, S., Xu, Z., & Han, X. (2025) · Molecular Neurodegeneration · doi:10.1186/s13024-025-00803-6 · Cited by 62
Self-citation
Alteration of Sphingolipids in Biofluids: Implications for Neurodegenerative Diseases
Pujol-Lereis, L. M. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20143564 · Cited by 69
The role of sphingolipids in endoplasmic reticulum stress
Park, W., & Park, J. (2020) · FEBS Letters · doi:10.1002/1873-3468.13863 · Cited by 67
Biochemical Markers and Risk Factors of Alzheimers Disease
Flirski, M., & Sobów, T. (2005) · Current Alzheimer Research · doi:10.2174/1567205052772704 · Cited by 67
Sphingolipid control of cognitive functions in health and disease
Kalinichenko, L. S., Gulbins, E., Kornhuber, J., & Müller, C. P. (2022) · Progress in Lipid Research · doi:10.1016/j.plipres.2022.101162 · Cited by 66
Improved Molecular Imaging in Rodent Brain with Time-of-Flight-Secondary Ion Mass Spectrometry Using Gas Cluster Ion Beams and Reactive Vapor Exposure
Angerer, T. B., Pour, M. D., Malmberg, P., & Fletcher, J. S. (2015) · Analytical Chemistry · doi:10.1021/ac504774y · Cited by 66
Sphingolipids in apoptosis, survival and regeneration in the nervous system
de Chaves, E. I. P. (2006) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2006.09.018 · Cited by 66
Alzheimer's disease and blood–brain barrier function—Why have anti-β-amyloid therapies failed to prevent dementia progression?
Pahnke, J., Walker, L. C., Scheffler, K., & Krohn, M. (2009) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2009.05.006 · Cited by 68
Sulfatides are endogenous ligands for the TLR4–MD-2 complex
Su, L., Athamna, M., Wang, Y., Wang, J., Freudenberg, M. A., Yue, T., Wang, J., Moresco, E. M. Y., He, H., Zor, T., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2105316118 · Cited by 65

Authors: Han, X., M. Holtzman, D., W. McKeel, D., Kelley, J., & Morris, J. C.
Affiliations: Washington University in St. Louis (US)
Corresponding author: Han, Xianlin
ORCID: Han, Xianlin
Morris, John C.
Venue: Journal of Neurochemistry
Publisher: Wiley
Published: 2002-08
Volume: 82
Issue: 4
Pages: 809-818
ISSN: 0022-3042 (ISSN-L)
1471-4159
DOI: 10.1046/j.1471-4159.2002.00997.x
OpenAlex: W1594975246
Cited by: 626
References: 56
Citations by year: 2026: 24 · 2025: 26 · 2024: 29 · 2023: 32 · 2022: 32 · 2021: 29 · 2020: 32 · 2019: 22 · 2018: 29 · 2017: 33 · 2016: 34 · 2015: 24 · 2014: 33 · 2013: 33 · 2012: 36
FWCI: 7.61
Type: journal article
Language: en
Open access: closed
Licence: onlinelibrary.wiley.com/termsAndConditions#vor (vor, 6 d)
Locations: Journal of Neurochemistry (publishedVersion)
PubMed (publishedVersion)
Funders: National Institutes of Health (5p41rr000954-34)
National Institute on Aging (P 50 AG05681, P50AG005681, P01 AG0 3991, P01AG003991)
National Center for Research Resources (P41RR00954-240043)
Topics: Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Sphingolipid Metabolism and Signaling
Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Keywords: Alzheimer's disease, sulfatide, ceramide, white matter, gray matter, brain lipid composition, pathogenesis
MeSH terms: Aged, Aged, 80 and over, Alzheimer Disease, Brain, Brain Chemistry, Ceramides, Dementia, Galactosylceramides, Humans, Neuropsychological Tests, Severity of Illness Index, Sphingomyelins, Sulfoglycosphingolipids, Sulfotransferases, Disease Progression, Spectrometry, Mass, Electrospray Ionization

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Substantial sulfatide deficiency and ceramide elevation in very early Alzheimer's disease: potential role in disease pathogenesis

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks